Biohaven
BHVN
187 hedge funds and large institutions have $1.6B invested in Biohaven in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 63 increasing their positions, 67 reducing their positions, and 22 closing their positions.
163% more call options, than puts
Call options by funds: $57.2M | Put options by funds: $21.8M
11% more capital invested
Capital invested by funds: $1.44B → $1.6B (+$156M)
1.4% more ownership
Funds ownership: 88.57% → 89.97% (+1.4%)
0% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 22
1% less funds holding
Funds holding: 188 → 187 (-1)
6% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 67
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$22.7M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$10.8M |
| 3 |
PA
Perceptive Advisors
New York
|
+$8.96M |
| 4 |
Walleye Capital
New York
|
+$7.68M |
| 5 |
ACM
Altium Capital Management
New York
|
+$5.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.5M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$9.61M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$8.24M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$6.68M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$5.42M |
BHVN Hedge Fund Activity: Q3 2023 in Review
187 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Biohaven (BHVN) for Q3 2023, worth a combined $1.6B — up 11% from $1.44B a quarter earlier.
Fund positioning in BHVN was balanced in Q3 2023: 22 funds opened new positions, 22 closed out, 63 added to existing stakes and 67 trimmed.
The largest buyer was State Street, adding an estimated $22.7M. The largest seller was Fidelity Investments, cutting an estimated $13.5M.
- 187 institutional investors held Biohaven (BHVN) as of Q3 2023, down from 188 in Q2 2023.
- Funds reported $1.6B of Biohaven stock for Q3 2023, up 11% quarter-over-quarter.
- 22 funds opened new Biohaven positions in Q3 2023 and 22 closed out, a net change of 0 holders.
- The largest Biohaven buyer in Q3 2023 was State Street, an estimated $22.7M added.
- The largest Biohaven seller in Q3 2023 was Fidelity Investments, an estimated $13.5M sold.
Based on aggregated 13F filings for Q3 2023.